Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells

References

• Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456–1462.
   PubMed Web of Science ®Google Scholar
• Saikumar P, Dong Z, Mikhailov V, . Apoptosis: definition, mechanisms, and relevance to disease. Am J Med 1999;107:489–506.
   PubMed Web of Science ®Google Scholar
• Jaattela M. Escaping cell death: survival proteins in cancer. Exp Cell Res 1999;248:30–43.
   PubMed Web of Science ®Google Scholar
• Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002;2:647–656.
   PubMed Web of Science ®Google Scholar
• Asanuma K, Moriai R, Yajima T, . Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res 2000;91:1204–1209.
   PubMedGoogle Scholar
• Altieri DC. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol 2006;18: 609–615.
   PubMed Web of Science ®Google Scholar
• Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 2008;8:61–70.
   PubMed Web of Science ®Google Scholar
• Kelland L. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. Clin Cancer Res 2007;13:4960–4963.
   PubMed Web of Science ®Google Scholar
• Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006;12:1133–1138.
   PubMed Web of Science ®Google Scholar
• Wojtyla A, Gladych M, Rubis B. Human telomerase activity regulation. Mol Biol Rep 2011;38:3339–3349.
   PubMed Web of Science ®Google Scholar
• Cerni C. Telomeres, telomerase, and myc. An update. Mutat Res 2000;462:31–47.
   PubMed Web of Science ®Google Scholar
• Endoh T, Tsuji N, Asanuma K, . Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription. Exp Cell Res 2005;305:300–311.
   PubMed Web of Science ®Google Scholar
• Sumi M, Tauchi T, Sashida G, . A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia. Int J Oncol 2004;24:1481–1487.
   PubMed Web of Science ®Google Scholar
• Harley CB. Telomerase and cancer therapeutics. Nat Rev Cancer 2008;8:167–179.
   PubMed Web of Science ®Google Scholar
• Damm K, Hemmann U, Garin-Chesa P, . A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J 2001;20:6958–6968.
   PubMed Web of Science ®Google Scholar
• Pascolo E, Wenz C, Lingner J, . Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate. J Biol Chem 2002;277:15566–15572.
   PubMed Web of Science ®Google Scholar
• De Cian A, Lacroix L, Douarre C, . Targeting telomeres and telomerase. Biochimie 2008;90:131–155.
   PubMed Web of Science ®Google Scholar
• El-Daly H, Kull M, Zimmermann S, . Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532. Blood 2005;105:1742–1749.
   PubMed Web of Science ®Google Scholar
• Uegaki K, Adachi N, So S, . Heterozygous inactivation of human Ku70/Ku86 heterodimer does not affect cell growth, double-strand break repair, or genome integrity. DNA Repair (Amst) 2006;5:303–311.
   PubMed Web of Science ®Google Scholar
• Beitzinger M, Oswald C, Beinoraviciute-Kellner R, . Regulation of telomerase activity by the p53 family member p73. Oncogene 2006;25:813–826.
   PubMed Web of Science ®Google Scholar
• John K, Alla V, Meier C, . GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria. Cell Death Differ 2011;18:874–886.
   PubMed Web of Science ®Google Scholar
• Melino G, Bernassola F, Ranalli M, . p73 induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem 2004;279:8076–8083.
   PubMed Web of Science ®Google Scholar
• Wang Z, Kyo S, Takakura M, . Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway. Cancer Res 2000;60:5376–5381.
   PubMed Web of Science ®Google Scholar
• Henderson YC, Breau RL, Liu TJ, . Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirus. Head Neck 2000;22:347–354.
   PubMed Web of Science ®Google Scholar
• Asanuma K, Kobayashi D, Furuya D, . A role for survivin in radioresistance of pancreatic cancer cells. Jpn J Cancer Res 2002;93:1057–1062.
   PubMedGoogle Scholar
• Ward RJ, Autexier C. Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment. Mol Pharmacol 2005;68:779–786.
   PubMed Web of Science ®Google Scholar
• Kamihira S, Yamada Y, Hirakata Y, . Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis. Br J Haematol 2001;114:63–69.
   PubMed Web of Science ®Google Scholar
• Hausladen DA, Wheeler MA, Altieri DC, . Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome. J Urol 2003; 170:230–234.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Iwamoto S, Gon G, . Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 2000;6:127–134.
   PubMed Web of Science ®Google Scholar
• Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007;35:495–516.
   PubMed Web of Science ®Google Scholar